Your Facial Rejuvenation Consultation at Goldenberg Dermatology, NYC
If you are interested in the latest advances in non-surgical facial rejuvenation, contact Goldenberg Dermatology in Manhattan to learn more about cutting-edge therapies. Dr. Gary Goldenberg and Dr. Kristina Goldenberg can recommend a customized plan to improve the texture and overall appearance of your skin.
Frequently Asked Questions
What is so special about umbilical cord stem cells? How is this treatment different from other stem cell treatments?
- The use of the Umbilical Cord tissue matrix is less invasive when compared to bone marrow aspiration, or adipose (fat) tissue extraction. This results in less pain, lowered morbidity and fewer complications for the patient and much shorter procedure time.
- The Mesenchymal Stem Cells or “MSC’s” that are currently being harvested from bone marrow and/or adipose (fat) tissue are less potent, lack the same proliferation and vary greatly in concentration. The MSCs that are extracted from fat and bone marrow is not able to secrete the full spectrum of growth factors.
- Umbilical Cord Tissue MSC’s are “young” perinatal cells. Because of the age and fitness of these cells, they are able to produce all of the necessary growth factors as compared to “older” adipose or bone marrow cells.
- Umbilical Cord Tissue MSC’s are simply more robust than other MSC’s from other sources. Range and level of specific cytokines that are greater and different from those expressed by fat-derived adult mesenchymal stem cells. The Umbilical Cord Tissue MSCs have a much higher rate of proliferation when compared MSC’s derived from either adipose or bone marrow.
- More importantly, the number and potency of MSC’s derived from “fat” is dependent on many factors: health and age of the patient, fitness of the patient, obesity, disease, smoking, etc. Liposuction aspirate contains far fewer MSC’s than Umbilical Cord tissue. Liposuction derived tissue ranges from 10,000 to 400,000 cells per 60cc. Corecyte Umbilical Cord Stem Cells contain 1 million live viable young perinatal MSC’s per 1cc post-thaw. (Centers of Excellence Third Party verified).
Where are the stem cells coming from and are they recently harvested?
Umbilical cord stem cells are obtained from C-section deliveries from normal, full-term pregnancies. Donors that consent to use of their birth tissues are carefully screened prior to the use of their tissues in manufacturing the product and all precautions are taken. The product is then screened again after the stem cells are extracted.
Have the stem cells been tested for disease? Are they being vetted and if so, how?
- Donors that consent to use of their birth tissues are carefully screened prior to the use of their tissues in manufacturing the stem cells.
- Comprehensive medical and social histories of the donors are obtained and tissues are procured, processed, and tested in accordance with standards established by the AATB and FDA requirements to minimize potential risks of disease transmission to recipients. Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.
- Each donor is tested for HBsAg (Hepatitis B Surface Antigen), HBcAb (hepatitis B core Antibody), HCV (hepatitis C Antibody), HIV I/II-Ab (Antibody to Human Immunodeficiency Virus Types 1 and Syphilis detection test, HIV NAT (HIV Nucleic Acid Test), and HCV NAT (HCV NucleicAcid Test).
- All products are tested post-sterilization to demonstrate the absence of bacterial and fungal pathogens and are non-pyrogenic. All testing results are reviewed by the Medical Director of Predictive Biotech (2749 E. Parleys Way, Suite 101, Salt Lake City, UT 84109) prior to the release of product.
Can I be allergic to Stem Cell Aesthetics?
- CoreCyteTM umbilical cord stem cells lack MHC-ll and HLA. Thus the product is immunomodulatory. The product does not elicit an allergic response.